Free Trial
NASDAQ:ICLR

Icon (ICLR) Stock Price, News & Analysis

Icon logo
$152.07 +1.54 (+1.02%)
Closing price 07/10/2025 04:00 PM Eastern
Extended Trading
$151.50 -0.57 (-0.37%)
As of 08:50 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Icon Stock (NASDAQ:ICLR)

Key Stats

Today's Range
$149.88
$155.90
50-Day Range
$126.62
$152.07
52-Week Range
$125.10
$347.72
Volume
1.51 million shs
Average Volume
1.11 million shs
Market Capitalization
$12.28 billion
P/E Ratio
16.57
Dividend Yield
N/A
Price Target
$198.08
Consensus Rating
Moderate Buy

Company Overview

Icon Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
90th Percentile Overall Score

ICLR MarketRank™: 

Icon scored higher than 90% of companies evaluated by MarketBeat, and ranked 108th out of 925 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Icon has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on 7 buy ratings, 7 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Icon has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Icon's stock forecast and price target.
  • Earnings Growth

    Earnings for Icon are expected to grow by 14.28% in the coming year, from $13.38 to $15.29 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Icon is 16.57, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.85.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Icon is 16.57, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.17.

  • Price to Earnings Growth Ratio

    Icon has a PEG Ratio of 1.84. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Icon has a P/B Ratio of 1.29. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Icon's valuation and earnings.
  • Percentage of Shares Shorted

    2.16% of the float of Icon has been sold short.
  • Short Interest Ratio / Days to Cover

    Icon has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Icon has recently increased by 19.31%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Icon does not currently pay a dividend.

  • Dividend Growth

    Icon does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.16% of the float of Icon has been sold short.
  • Short Interest Ratio / Days to Cover

    Icon has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Icon has recently increased by 19.31%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Icon has a news sentiment score of 0.57. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 11 news articles for Icon this week, compared to 9 articles on an average week.
  • MarketBeat Follows

    2 people have added Icon to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Icon insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    44.00% of the stock of Icon is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    95.61% of the stock of Icon is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Icon's insider trading history.
Receive ICLR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Icon and its competitors with MarketBeat's FREE daily newsletter.

ICLR Stock News Headlines

ICLR | Icon PLC Quarterly Cash Flow Statement - MarketWatch
ICLR | Icon PLC Annual Income Statement - MarketWatch
Google did what!?!?
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
See More Headlines

ICLR Stock Analysis - Frequently Asked Questions

Icon's stock was trading at $209.71 at the beginning of the year. Since then, ICLR shares have decreased by 27.5% and is now trading at $152.07.

Icon Plc (NASDAQ:ICLR) issued its quarterly earnings results on Wednesday, April, 30th. The medical research company reported $3.19 EPS for the quarter, topping analysts' consensus estimates of $3.17 by $0.02. The business's revenue for the quarter was down 4.3% compared to the same quarter last year.
Read the conference call transcript
.

The following companies are subsidiaries of Icon: PRA Health Sciences, MedPass International, MeDiNova Research, MolecularMD, Mapi Group, Clinical Research Management, PMG Research, and more.

Top institutional investors of Icon include Canoe Financial LP (0.24%), Eldred Rock Partners LLC (0.07%), Financiere des Professionnels Fonds d investissement inc. (0.06%) and Swedbank AB (0.05%).

Shares of ICLR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Icon investors own include NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), Meta Platforms (META), Adobe (ADBE), Novo Nordisk A/S (NVO) and Jabil (JBL).

Company Calendar

Last Earnings
4/30/2025
Today
7/10/2025
Next Earnings (Estimated)
7/23/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Business Services
Current Symbol
NASDAQ:ICLR
CIK
1060955
Employees
41,900
Year Founded
1990

Price Target and Rating

High Price Target
$311.00
Low Price Target
$150.00
Potential Upside/Downside
+30.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.60
Research Coverage
15 Analysts

Profitability

EPS (Trailing Twelve Months)
$9.18
Trailing P/E Ratio
16.57
Forward P/E Ratio
11.37
P/E Growth
1.84
Net Income
$791.47 million
Net Margins
9.25%
Pretax Margin
10.10%
Return on Equity
11.46%
Return on Assets
6.49%

Debt

Debt-to-Equity Ratio
0.36
Current Ratio
1.27
Quick Ratio
1.27

Sales & Book Value

Annual Sales
$8.28 billion
Price / Sales
1.48
Cash Flow
$20.25 per share
Price / Cash Flow
7.51
Book Value
$117.92 per share
Price / Book
1.29

Miscellaneous

Outstanding Shares
80,760,000
Free Float
45,224,000
Market Cap
$12.28 billion
Optionable
Optionable
Beta
1.17

Social Links

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:ICLR) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners